Sunitinib, sold under the brand name Sutent, is an anti-cancer medication. [2] It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the …

2024年8月8日 · What is sunitinib? Sunitinib is used to treat certain types of advanced or progressive tumors of the stomach, intestines, esophagus, pancreas, or kidneys. Sunitinib …

舒尼替尼 （INN： Sunitinib），商标名 索坦 （Sutent），是一种口服的小分子多靶点 受体酪氨酸激酶 抑制剂，2006年1月26日被 FDA 批准用于治疗对标准疗法没有响应或不能耐受的 胃肠道 …

舒尼替尼（Sunitinib，Sutent）是一种新型多靶向性的治疗肿瘤的口服药物。 舒尼替尼的首要开发目标为，用于治疗对标准疗法没有响应或不能耐受之胃肠道基质肿瘤和转移性肾细胞癌。

Sunitinib is used to treat gastrointestinal stromal tumors (GIST; a type of tumor that grows in the stomach, intestine (bowel), or esophagus (tube that connects the throat with the stomach) in …

Sunitinib is a small-molecule multi-targeted receptor tyrosine kinase (RTK) inhibitor. On January 26, 2006, the agent was formally approved by the US FDA for the indications of treating renal …

舒尼替尼（Sunitinib，商品名Sutent，也称索坦）是一种新型多靶向性的口服药物，广泛用于治疗多种病症。 目前舒尼替尼已经在国内上市，本文就舒尼替尼的适应症、用法用量、副作用、 …

Sunitinib is an oral oxindole multitargeted kinase inhibitor that inhibits certain receptor tyrosine kinases (RTKs). These include vascular endothelial growth factor receptors (VEGFR type 1 …

(sunitinib malate) capsules: What is the most important information I should know about SUTENT? SUTENT can cause serious side effects including: Severe liver problems, that can …

||SUTENT is used to treat adults with kidney cancer that has not spread (localized) and who are at high risk of RCC coming back again after having kidney surgery. It is not known if SUTENT is …